HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$313M |
| 2 |
Advanced Micro Devices
AMD
|
+$209M |
| 3 |
TSMC
TSM
|
+$168M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$160M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
Amazon
AMZN
|
+$643M |
| 3 |
Apple
AAPL
|
+$535M |
| 4 |
Procter & Gamble
PG
|
+$463M |
| 5 |
AstraZeneca
AZN
|
+$414M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Consumer Discretionary | 11.99% |
| 3 | Financials | 11.42% |
| 4 | Healthcare | 10.42% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Workhorse Group
WKHS
$33.2M
| $65K | ﹤0.01% |
+4
| New | +$44.1K |
|
|
ORLA
3177
DELISTED
Orla Mining
ORLA
| $64K | ﹤0.01% |
13,032
+190
| +1% | +$764 |
|
3178
Solid Biosciences
SLDB
$794M
| $64K | ﹤0.01% |
3,582
| – | – |
|
|
NETI
3179
DELISTED
Eneti Inc.
NETI
| $64K | ﹤0.01% |
10,038
-2,095
| -17% | -$14.2K |
|
3180
Bionano Genomics
BNGO
$12.3M
| $63K | ﹤0.01% |
40
+2
| +5% | +$2.7K |
|
|
PVLA
3181
Palvella Therapeutics
PVLA
$1.99B
| $63K | ﹤0.01% |
257
+92
| +56% | +$24.2K |
|
|
ML
3182
DELISTED
MoneyLion Inc.
ML
| $63K | ﹤0.01% |
823
-59
| -7% | -$4.6K |
|
3183
Senseonics Holdings Inc
SENS
$263M
| $61K | ﹤0.01% |
1,562
+15
| +1% | +$687 |
|
|
FIRY
3184
Firy Inc
FIRY
$148M
| $61K | ﹤0.01% |
996
-3,869
| -80% | -$315K |
|
3185
ADMA Biologics
ADMA
$1.96B
| $59K | ﹤0.01% |
31,968
| – | – |
|
3186
BioAtla
BCAB
$5.46M
| $59K | ﹤0.01% |
+237
| New | +$99.1K |
|
|
EGIO
3187
DELISTED
Edgio, Inc. Common Stock
EGIO
| $59K | ﹤0.01% |
278
+17
| +7% | +$2.83K |
|
|
PAYA
3188
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $59K | ﹤0.01% |
+10,142
| New | +$61.2K |
|
3189
Hims & Hers Health
HIMS
$6.43B
| $57K | ﹤0.01% |
10,634
+33
| +0.3% | +$163 |
|
|
LOGC
3190
DELISTED
ContextLogic
LOGC
| $57K | ﹤0.01% |
846
+29
| +4% | +$2.05K |
|
3191
Ocugen
OCGN
$416M
| $55K | ﹤0.01% |
16,634
+146
| +0.9% | +$513 |
|
|
DOMA
3192
DELISTED
Doma Holdings, Inc.
DOMA
| $55K | ﹤0.01% |
989
| – | – |
|
|
IVC
3193
DELISTED
Invacare Corporation
IVC
| $54K | ﹤0.01% |
+37,821
| New | +$80.9K |
|
|
CVAC
3194
DELISTED
CureVac
CVAC
| $53K | ﹤0.01% |
2,720
+2,220
| +444% | +$44.3K |
|
|
TCRR
3195
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $53K | ﹤0.01% |
19,094
| – | – |
|
3196
Q32 Bio
QTTB
$466M
| $52K | ﹤0.01% |
969
+11
| +1% | +$683 |
|
3197
Honda
HMC
$39.1B
| $51K | ﹤0.01% |
1,788
+17
| +1% | +$499 |
|
3198
Hippo Holdings
HIPO
$830M
| $50K | ﹤0.01% |
990
+7
| +0.7% | +$362 |
|
3199
Inseego
INSG
$114M
| $50K | ﹤0.01% |
+1,226
| New | +$56.1K |
|
3200
Akebia Therapeutics
AKBA
$354M
| $49K | ﹤0.01% |
69,107
-25,028
| -27% | -$53.5K |
|
Similar funds
HSBC Holdings's Q1 2022 Portfolio in Review
As of Q1 2022, HSBC Holdings held 3,586 positions worth $82.3B, down 24% from $108B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
HSBC Holdings withdrew a net $19.7B in Q1 2022, closing 339 positions and reducing 1,273 holdings. Its most notable exit was Xilinx Inc, an estimated $127M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, HSBC Holdings opened a new position in iShares Global Energy ETF worth $110M.
- HSBC Holdings's largest Q1 2022 buy was iShares Global Energy ETF: 3,037,936 shares worth $110M.
- HSBC Holdings added most to Meta Platforms (Facebook) in Q1 2022, an estimated $313M increase.
- HSBC Holdings's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- HSBC Holdings fully exited Xilinx Inc in Q1 2022, selling an estimated $127M.
- HSBC Holdings's ten largest holdings make up 25% of its $82.3B portfolio in Q1 2022.
- HSBC Holdings opened 347 new positions and closed 339 in Q1 2022.
- HSBC Holdings's portfolio value fell 24% quarter-over-quarter to $82.3B.
Based on HSBC Holdings's 13F filing for Q1 2022, filed 16 May 2022.